510(k) Report

510(k) · Cleared

Cleared

Salter Labs Pep Device

K991788510(k) TraditionalCleared Aug 6, 199973-day reviewClass II21 CFR 868.5630

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Salter Labs · CAF Nebulizer (Direct Patient Interface)

Cleared on Aug 6, 1999 as substantially equivalent to K972042 (Pari Holding Co., 1997) and 2 other predicates after a 73-day review. Its family tree reaches back 1 generation to 1996.

Decided
Aug 6, 1999
Review
73 days
Class
Class II
Product code
CAF
Recalls
None
Predicates
3

Its longest line of descent runs back 1 generation to K954492 (1996). 3 ancestors in all. No later device cites it as a predicate yet.

Other ancestors, by year cleared 1998: 1 other ancestor1997: 1 other ancestorK954492 · Mercury Medical Expiratory Resistance Exerciser, Resistex · Mercury Medical · 1996199619982000
Other ancestors, by generation 1 generation back: 2 other ancestors K954492 · Mercury Medical Expiratory Resistance Exerciser, Resistex · Mercury Medical · 19960
  1. Root · 1 generation backK954492 Mercury Medical Expiratory Resistance Exerciser, ResistexMercury Medical · 1996
  2. This deviceK991788 Salter Labs Pep DeviceSalter Labs · 1999
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K954492Mercury Medical Expiratory Resistance Exerciser, ResistexMercury Medical1996—
0 (this device)K991788Salter Labs Pep DeviceSalter Labs1999—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199710
199810
FIG. 1 — Lineage of K991788, 1996–1999Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in CAF? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new CAF device

  1. #1 K260270 FindAir ONE for pMDI (FAO-MDI-V12-GRE-001)score 13.2 · 7 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K972042Pari Pep Therapy System
Summary page 3
…radually decreasing orifice size corresponding to the increase in setting number. b. Predicate Devices: Product: Manufacturer: 510(k) Number: Pari #783 PEP Device Pari K972042 Breather PEP Device Instrumentation Industries, Inc. K980725 Expiratory Resistance Exerciser | Mercury Medical K954492 Table 3.1…
Pari Holding Co.1997—
*K980725Exhalation Valve (BE 30-115-B, NS 30-115-U, NS 30-115-5, PS 54-a)
Summary page 3
…e in setting number. b. Predicate Devices: Product: Manufacturer: 510(k) Number: Pari #783 PEP Device Pari K972042 Breather PEP Device Instrumentation Industries, Inc. K980725 Expiratory Resistance Exerciser | Mercury Medical K954492 Table 3.1 Predicate Devices Salter Labs 510(k) Submission for PEP Dev…
Instrumentation Industries, Inc.1998—
*K954492Mercury Medical Expiratory Resistance Exerciser, Resistex
Summary page 3
…facturer: 510(k) Number: Pari #783 PEP Device Pari K972042 Breather PEP Device Instrumentation Industries, Inc. K980725 Expiratory Resistance Exerciser | Mercury Medical K954492 Table 3.1 Predicate Devices Salter Labs 510(k) Submission for PEP Device 39 ¢. Comparative Product Matrix The…
Mercury Medical1996—

Also cleared against K972042: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • None of the 3 ancestors has a recall.
  • 1 other device also cites its predicate K972042.

How does its category compare?

All CAF devices

CAF Nebulizer (Direct Patient Interface): FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · CAF

7in 2025

2007: 182008: 122009: 82010: 102011: 102012: 92013: 92014: 92015: 82016: 52017: 82018: 92019: 32020: 62021: 82022: 42023: 82024: 42025: 72026 (partial year): 2
2007high 18 (2007) · low 3 (2019)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · CAF

211in 2025

2007: 98 days median2008: 123 days median2009: 163 days median2010: 114 days median2011: 157 days median2012: 126 days median2013: 238 days median2014: 151 days median2015: 186 days median2016: 186 days median2017: 253 days median2018: 161 days median2019: 266 days median2020: 219 days median2021: 324 days median2022: 176 days median2023: 279 days median2024: 251 days median2025: 211 days median
2007high 324 (2021) · low 98 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · CAF

1in 2018

2007: 12011: 12014: 52015: 32016: 12017: 14, 13 Class I2018: 1
2007high 14 (2017) · low 0 (2008)2026

Class I (13 since 2007) Class II/III not classified

Adverse event reports per year · CAF

191in 2025

2007: 262008: 112009: 152010: 372011: 2372012: 1382013: 2172014: 1232015: 1662016: 2012017: 2562018: 1622019: 1852020: 1172021: 1612022: 552023: 1072024: 1022025: 191
2007high 256 (2017) · low 11 (2008)2025

MAUDE reports naming product code CAF, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071898126
200812123011
20098163015
201010114037
2011101571237
201291260138
201392380217
201491515123
201581863166
201651861201
2017825314 (13)256
201891611162
201932660185
202062190117
202183240161
20224176055
202382790107
202442510102
202572110191
20262—0—

What is it indicated for?

This product is indicated for use in patients where enhanced medicated aerosol deposition or lung exercise is recommended by a physician or licensed clinician. This device is intended to be used in the hospital, clinic and home care markets, The Salter Labs PEP device is designed to be used with the Salter Labs Nebutech Nebulizer-series Mouthpiece as a stand-alone device, or the device may be used in conjunction with the Salter Labs Nebutech Nebulizer…

Read the full statement (127 words)

This product is indicated for use in patients where enhanced medicated aerosol deposition or lung exercise is recommended by a physician or licensed clinician. This device is intended to be used in the hospital, clinic and home care markets,

The Salter Labs PEP device is designed to be used with the Salter Labs Nebutech Nebulizer-series Mouthpiece as a stand-alone device, or the device may be used in conjunction with the Salter Labs Nebutech Nebulizer and the Salter Labs Aerosol Filter during the nebulization process.

This product is a nebulizer accessory that connects to the exhalation port of the Salter Labs Nebutech Nebulizer mouthpiece and serves to provide a controllable exhalation resistance of from 5 to 20 cm H20 at flow rates ranging from 10 to 55 L/min,

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K991788: Salter Labs Pep Device.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K991788

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026